ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,907Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 65

$536K Total Retail Price of All Prescriptions

Rank: 8 out of 65

468 Patients Receiving at Least One Drug in Part D
95% Patients 65 Years and Older
52% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Maryland
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

5% of this provider’s 468 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

5% of this provider’s 468 patients filled at least one prescription for a schedule three drug, compared to an average of 3%.

Brand Name Drugs

20% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$49 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Maryland
FUROSEMIDE 416 401 88 1 3
LEVOTHYROXINE SODIUM 375 370* 77 2 1
AMLODIPINE BESYLATE 308 303* 76 3 2
METOPROLOL TARTRATE 255 250* 58 4 6
LOVASTATIN 236 225 36 5 40
OMEPRAZOLE 234 229* 56 6 8
MIRTAZAPINE 225 220* 39 7 10
LISINOPRIL 224 209 63 8 4
DONEPEZIL HCL 223 223 39 9 12
JANTOVEN 191 191 21 10 31
PANTOPRAZOLE SODIUM 189 189 38 11 20
ATORVASTATIN CALCIUM 179 174* 47 12 5
ESCITALOPRAM OXALATE 166 161* 27 13 26
POTASSIUM CHLORIDE 158 158 36 14 25
TRAMADOL HCL 147 142* 48 15 11
WARFARIN SODIUM 146 146 28 16 9
GABAPENTIN 139 134* 28 17 19
CITALOPRAM HBR 129 129 25 18 22
TAMSULOSIN HCL 129 115 18 18 28
METOPROLOL SUCCINATE 121 116* 30 20 14
RANITIDINE HCL 119 114* 21 21 29
CLOPIDOGREL 118 118 26 22 24
SIMVASTATIN 109 104* 32 23 7
TRAZODONE HCL 108 108 31 24 23
LEVOFLOXACIN 106 101* 53 25 53
SERTRALINE HCL 103 98* 17 26 17
NAMENDA 101 101 19 27 21
CYMBALTA 95 83 12 28 32
PREDNISONE 92 87* 30 29 38
HYDROCHLOROTHIAZIDE 90 85* 23 30 15
ATENOLOL 87 82* 21 31 30
TRIAMTERENE-HCTZ 85 80* 25 32 112
SPIRONOLACTONE 80 65 18 33 61
POLYETHYLENE GLYCOL 3350 80 80 22 33 41
LOSARTAN POTASSIUM 78 73* 16 35 16
ALLOPURINOL 75 70* 17 36 52
DIGOX 75 75 12 36 65
IPRATROPIUM-ALBUTEROL 69 69 27 38 54
IBUPROFEN 68 42 15 39 99
CRESTOR 68 63* 14 39 63
CARVEDILOL 68 <11 <11 39 36
ISOSORBIDE MONONITRATE ER 66 66 11 42 80
NYSTATIN 65 60* 16 43 81
DIOVAN 62 <11 <11 44 37
LIDODERM 62 62 15 44 87
PRAVASTATIN SODIUM 61 56* 17 46 13
METFORMIN HCL 61 56* 15 46 18
KLOR-CON M10 59 59 17 48 138
LATANOPROST 59 59 12 48 103
LORAZEPAM 57 52* 17 B 50 34
QUETIAPINE FUMARATE 56 <11 <11 A 51 27
MONTELUKAST SODIUM 56 <11 <11 51 89
DOXYCYCLINE HYCLATE 54 54 29 53 106
PAROXETINE HCL 52 47* 12 54 85
OXYBUTYNIN CHLORIDE ER 52 <11 <11 54 93
HYDROCODONE-ACETAMINOPHEN 51 46* 21 S3 56 47
ADVAIR DISKUS 50 50 13 57 45
LIDOCAINE 50 <11 <11 57 162
AZITHROMYCIN 50 50 32 57 77
BUMETANIDE 50 <11 <11 57 162
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 15, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.